GCM
ELAN icon

Gladius Capital Management’s Elanco Animal Health ELAN Stock Holding History

Gladius Capital Management’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,457
Closed -$27.6K – 351
2023
Q3 		$27.6K Sell
2,457
-57
-2% -$662 ﹤0.01% 316
2023
Q2 		$25.3K Sell
2,514
-102
-4% -$947 ﹤0.01% 284
2023
Q1 		$24.6K Sell
2,616
-289
-10% -$3.41K ﹤0.01% 312
2022
Q4 		$35.5K Buy
2,905
+521
+22% +$6.49K ﹤0.01% 271
2022
Q3 		$30K Buy
2,384
+1,413
+146% +$24.7K ﹤0.01% 305
2022
Q2 		$20K Buy
+971
New +$23K ﹤0.01% 318

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Gladius Capital Management's ELAN Position: Q4 2023 in Review

Gladius Capital Management sold out of Elanco Animal Health (ELAN) in Q4 2023, closing a stake of 2,457 shares — an estimated $27.6K sold.

Gladius Capital Management first reported a position in ELAN in Q2 2022 and held it in 6 quarters. The position peaked at $35.5K in Q4 2022. 354 funds tracked by Wall St. Rank hold ELAN as of Q4 2023.

  • Gladius Capital Management reported no remaining Elanco Animal Health position as of Q4 2023 after selling out during the quarter.
  • Gladius Capital Management sold 2,457 Elanco Animal Health shares in Q4 2023, an estimated $27.6K.
  • Gladius Capital Management first reported a position in Elanco Animal Health in Q2 2022 and held it in 6 quarters.
  • Gladius Capital Management's Elanco Animal Health position peaked at $35.5K in Q4 2022.
  • 354 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2023.

Based on Gladius Capital Management's 13F filing for Q4 2023, filed 7 Feb 2024.